Nuo Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 18 Sep 24 | BuyUS$93,750 | Charles Sheedy | Individual | 125,000 | US$0.75 | |
| 20 May 24 | BuyUS$75,000 | Charles Sheedy | Individual | 100,000 | US$0.75 | |
| 19 Dec 23 | BuyUS$75,000 | Charles Sheedy | Individual | 150,000 | US$0.50 |
Insider Trading Volume
Insider Buying: AURX insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 2,187,864 | 4.7% |
| Private Companies | 4,900,000 | 10.5% |
| General Public | 17,501,298 | 37.6% |
| Individual Insiders | 22,009,243 | 47.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.1%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 11,440,865 | US$13.3m | 1.1% | no data | |||
| 5,178,345 | US$6.0m | 0% | no data | |||
| 4,900,000 | US$5.7m | 0% | no data | |||
| 2,800,000 | US$3.2m | 12% | no data | |||
| 2,183,164 | US$2.5m | 0% | 0.03% | |||
| 1,975,358 | US$2.3m | 0% | no data | |||
| 589,675 | US$684.0k | 0% | no data | |||
| 25,000 | US$29.0k | 0% | no data | |||
| 4,700 | US$5.5k | 0% | no data |